myHealthbox presents its multi-language eLeaflet solution at Cosmopack, Bologna

It is now common in our society that different ethnic groups and languages meet and coexist in the same country, in Italy alone there are now more than 5 million people that speak a primary language that is different from Italian (Romanian, Albanian and Arabic are amongst the most spoken). To these language minorities we can then add turists and travellers that live in Italy and speak one of the main European languages (English, Spanish and German are the main ones).

It is easy to see how, when the is a need to read information about the use of medicines of healthcare products (for example the dosage) these people would prefer reading information in their native language which they consider “safer” as less subject to interpretation errors.

Moreover there are in the world dozens of situations where 2 or more official languages are present in the same country (i.e. German in the Alto Adige region in Italy or French and Dutch in Belgium).

In Italy for example there is a requirement, for product sold in the Alto Adige region, for providing patient information in Italian and in German; until recently compliance was achieved by providing two printed versions of the patient information leaflet inside the packaging,today an alternative solution is available by making available a digital versions of the leaflet in German language via web or mobile, these can be also easily printed in the pharmacy upon request.

To provide an answer to these crucial requirement in today’s healthcare communication myHealthbox has extended its eLeaflet product with native support for 35 languages.

The use of myHealthbox as the digital leaflets distribution platform, the data security solutions implemented (both at leaflet and platform level) and the possibility of providing this information also via a QR code printed on the packaging make myHealthbox the solution of choice for those companies that need to satisfy government requirements for selling healthcare product in bi- or multi-lingual regions like Alto Adige in Italy.

To find out more visit us at Cosmopack in Bologna or contact us at sales@myhealthbox.eu

myHealthbox presenta la soluzione eLeaflet con supporto multilingua al Cosmopack di Bologna

Oggi più che mai viviamo in una realtà dove diverse etnie e lingue si incontrano e convivono nello stesso paese, solo in Italia si contano più di 5 milioni di persone che non hanno l’italiano come lingua principale (Romeno, Albanese e Arabo sono le lingue principali) oltre naturalmente a turisti e persone che sono presenti in Italia per lavoro e che parlano una delle altre lingue Europee (Inglese, Spagnolo e tedesco sono le principali).

Si può facilmente capire come, quando si tratta di leggere informazioni sull’uso di medicinali o prodotti per la salute (ad es. la posologia di una farmaco), queste persone preferiscano usare la propria lingua nativa che ritengono istintivamente più “sicura” e meno soggetta ad errori di interpretazione.

Ci sono poi nel mondo decine di realtà dove 2 o più lingue ufficiali coesistono all’interno dello stesso paese (come ad esempio la lingua Tedesca in Alto Adige o Francese ed Olandese in Belgio).

In Italia esiste l’obbligo, per i farmaci venduti in Alto Adige, di fornire le informazioni per il paziente sia in Italiano che in Tedesco; fino a poco tempo fa esistevano 2 versioni cartacee del foglio illustrativo, oggi è possibile utilizzare versioni digitali del foglio in Tedesco disponibili sia tramite web e mobile che stampabili in farmacia su richiesta.

A tutte queste esigenze ha risposto myHealthbox con il suo prodotto eLeaflet che include il supporto nativo per oltre 35 lingue.

La distribuzione dei fogli illustrativi digitali attraverso la piattaforma myHealthbox, le soluzioni di sicurezza dei dati implementate (sia a livello di formato che di piattaforma) e la possibilità di accedere a queste informazioni anche tramite un QR code sulla confezione permettono di ottemperare a tutti i requisiti stabiliti dal Ministero della Salute e da AIFA in termini di soluzioni per il bilinguismo sia specificatamente per la regione Alto Adige che per altre regioni.

Per saperne di più potete venire a visitare in nostro stand al Cosmopack di Bologna o contattarci via email all’indirizzo sales@myhealthbox.eu

myHealthbox adds support for medicine compliance monitoring

myHealthbox launches a new fully-digital medication adherence monitoring solution.

In medicine, compliance (also adherence or therapeutic adherence) describes the degree to which a patient correctly follows medical advice.

When we refer specifically to Medication Adherence we can say that this occurs when a patient takes their medications according to the prescribed dosage, time, frequency, and direction.  A breakdown in any one of these elements (missing doses, misinterpreting directions for use, or abandoning therapy altogether) is called non-compliance and has the potential to result in unanticipated side effects and complications including re-hospitalization.

Studies published in the New England Journal of Medicine showed that:

  • Half of all patients do not take their medications as prescribed (with varying degrees of non-compliance)
  • More than 1 in 5 new prescriptions go unfilled
  • Adherence is lowest among patients with chronic illnesses (but patients with chronic illnesses are also the easiest to monitor as they make repeated visits to the doctor or pharmacy where compliance can be verified and discussed).

Both the patient and the health-care provider affect compliance, and a positive physician-patient relationship is the most important factor in improving compliance.

When a direct patient-care provider relationship is missing (like for OTC medications for example) clear instructions covering how to use the medicine and complete information about the risks of non compliance are the main factors that can affect compliance either in a positive or negative way.

Medication non-adherence has long been a major issue for health and healthcare costs. According to one study, “Patient non-adherence to prescribed medications is associated with poor therapeutic outcomes, progression of disease, and an estimated burden of billions per year in avoidable direct health care costs.”

A substantial and growing body of evidence supports the, intuitive, notion that patients who adhere to their medication regimen have better health outcomes and lower total healthcare spending. For example, one study from 2011 showed that average benefit-cost ratios associated with patient adherence ranged from 3.1:1 to 10.1:1 for the chronic health conditions measured, with beneficial effects of adherence more pronounced (3.8:1 to 13.5:1) in older patients across most conditions studied.

Despite this mounting evidence, overall average drug adherence in the United States is poor, especially with therapies used to treat chronic and costly medical conditions—the conditions that plan sponsors are particularly concerned about. Evidence supporting overall dismal adherence abounds. For example, one study found that only 51 percent of patients treated for high blood pressure were adherent to their prescribed treatment.

Hospitalizations, re-hospitalizations and nursing-home admissions are recognized as direct costs of medication non-adherence in the elderly. However medication non-adherence in the elderly may also result in disease progression. It is obviously very difficult to monitor and estimate the costs of non-compliance for all OTC medications or prescription drugs that do not require mid- or end-of therapy checks by the care provider (in most cases a doctor or a pharmacists).

Among the main reasons for poor medication compliance are: avoidance of troublesome side effects, poor understanding of the medication, forgetfulness, cognitive decline, intentional under-dosage, economic limitations. It needs to be noted that these are not dependent on the type of medicine be it expensive medications for chronic diseases or over the counter drugs.

New progress in personalized medicine and digital health has exciting potential to significantly reduce costs and improve the health for those with chronic medical conditions like asthma, depression, diabetes and HIV/AIDS. While some obstacles for medication adherence may be difficult to overcome, like the high cost of many medications, others may be surmounted through technology and new partnerships.

These digital solutions have overlooked the issue of non-compliance when related to OTC and low-cost prescription medications as these solutions tend to be fairly expensive and thus applicable only to cases where either the drug is already very expensive or the costs of non-compliance is very high and can be in some way estimated.

The fact is that medication adherence is a complex public health challenge, and while better adherence can improve health outcomes and lower overall health care costs, for both patients and payers, evidence of a working solution, either digital or not, has yet to be provided.

The top digital solutions to improving medication compliance

There are a number of approaches to trying to solve this problem, some of these are:
– Gamification (Mango Health app.) and Play-it Health
Proteus Digital Health’s ingestible sensor
Pill box reminders and digital pillbox solutions
In-pharmacy monitoring services.

Under a typical medication adherence monitoring program (whether carried out at he point of sale/pharmacy or at the care provider or remotely), patients and/or providers are alerted to probable instances of non-adherence and encouraged to use the drug therapy as prescribed.

The top questions to ask a medication compliance monitoring solution

Despite recognition of a valuable problem affecting both personal health and companies budgets the big questions remains:

  • Can Digital Health Solutions really improve Medication Adherence?
  • Can they be low cost? Or better are they cost effective in any scenario?
  • Can they be easily applied to any medication?
  • Can they cover the educational part besides any scheduling and monitoring functionalities ?

The myHealthbox solution

While many companies and solutions are looking at medication adherence for chronic diseases and for patients with complex and multi-medications schedules most fail to understand that helping patients understand the specific product and monitoring compliance must be part of the same solution. A cost-effective solution must applicable in any cost and market scenario.

For example few talk about medication adherence when looking at antibiotic therapies but in fact poor adherence for these drugs is one of the major causes of an increasing poor response to antibiotics in young populations, antibiotics abuse, poor eradication of bacterial infections at the end of a therapy and eventually increasing indirect health costs.

To better address these needs myHealthbox is now offering an easy and affordable solution to monitor compliance that integrates its eLeaflet product with an easy-to-use scan and monitor digital service that can be easily integrated into any product physical packaging.

This is what make the compliance monitoring solution by myHealthbox unique :

  • it integrates seamlessly into the secure myHealthbox platform used by millions of people worldwide
  • it does not require a dedicated mobile app.
  • it does not require additional, costly hardware
  • it integrates easily into any physical packaging with minimal costs.

To know more about the myHealthbox platform and our non-compliance monitoring solution please contact sales@myhealthbox.eu

myHealthbox extends its coverage to China

myHealthbox continues extending coverage for official information on all medicines and healthcare products available on the planet by adding support for products available in China.

Information on medicinal products and offical information leaflets are already available and searchable through all myHealthbox clients and to third parties via the myHealtbox web API.

This addition brings the total number of countries supported by the myHealthbox platform to 51.

myHealthbox extends its coverage to Bangladesh

myHealthbox continues extending coverage for official information on all medicines and healthcare products available on the planet by adding support for products available in Bangladesh.

Information on medicinal products and offical information leaflets are already available and searchable through all myHealthbox clients and to third parties via the myHealtbox web API.

This addition brings the total number of countries supported by the myHealthbox platform to 50.

myHealthbox extends its coverage to Tanzania

myHealthbox continues extending coverage for official information on all medicines and healthcare products available on the planet by adding support for products available in Tanzania.

Information on medicinal products and offical information leaflets are already available and searchable through all myHealthbox clients and to third parties via the myHealtbox web API.

This addition brings the total number of countries supported by the myHealthbox platform to 49.

myHealthbox extends its coverage to Armenia

myHealthbox continues extending coverage for official information on all medicines and healthcare products available on the planet by adding support for products available in Armenia.

Information on medicinal products and offical information leaflets are already available and searchable through all myHealthbox clients and to third parties via the myHealtbox web API.

This addition brings the total number of countries supported by the myHealthbox platform to 48.

myHealthbox extends support for information on plants products available in Germany

myHealthbox continues extending coverage for official information on all medicines available on the planet by adding support for plants products available in Germany.

Information on herbicide (herbizid) products and official technical documents are already available and searcheable through all myHealthbox clients.

myHealthbox extends support for information on human medicines available in Malta

myHealthbox continues extending coverage for official information on all medicines available on the planet by adding support for products available in Malta. Information on medicinal products and offical information leaflets are already available and searchable through all myHealthbox clients.

The Digital Content Revolution in Healthcare

Introduction
With the rise of internet users to over 3 billion, and 175 million Google searches per day for health-related information, the demand for digital, accessible and trustworthy
information on health products is greater than ever.
This white paper highlights current trends in internet use and digital channels, looks at
the global health products market and discusses the availability and quality of
information of medicines and health products which are to be found online.
It demonstrates how the demand from consumer and health professionals for simple and
high quality information, and for those companies wanting to engage with them, could be
found in the services of myHealthbox, the largest, independent, source of digital
healthcare information, providing freely available, trustworthy data for both consumers
and professionals, and so ultimately improving patient knowledge and safety.

The internet today
It is without doubt no-one could have estimated the massive success of the internet when
Sir Tim Berners-Lee invented the World Wide Web in 1989, nor that it would spread to be
a truly global phenomenon and become the most powerful communication medium ever
known, providing open access to everyone.
Currently, the Internet Live Stats * website records the number of internet users as over 3
billion, with around 40% of the world’s population having internet connection across all
five continents.

Internet users in the world

Internet users in the world

Internet users by region

Internet users by region

As the World Wide Web celebrates its 25 th Anniversary, the digital age is changing rapidly.
Google, where 78% of web searches begin, leads the innovation field; and millions of
online services and innovative applications now exist for almost every possible subject
providing opportunities to expand knowledge and directly engage with consumers.

The global growth of the health products market
In parallel with the enormous growth of internet users, the forecasts for global spending
on medicines are equally astounding. A recent IMS independent study predicts spending
on medicines will hit a phenomenal $1.3 trillion by 2018, an increase from $989 billion in
2014, driven by global economic recovery, growing and ageing populations, drug
innovation, improved diagnosis and treatment trends, and extended health coverage
around the world.

IMS forecast for global pharmaceutical market spending and growth 2008-2018 (US$)

IMS forecast for global pharmaceutical market spending and growth 2008-2018 (US$)

The USA, the EU5 (France, Germany, Italy, Spain and UK) and Japan traditionally lead the spending on global medicines, however the “pharmerging” countries * will represent an
increasing share of the global market. These nations are improving healthcare access
with government funded programs; they are also promoting healthy living and disease
prevention, encouraging the use of over-the-counter health products as a solution to
reducing direct costs to their health systems.

The rise of the internet as a source of health-related information
In recent years numerous studies have set out to establish the extent and type of internet
use to obtain health-related information by consumers, either for independent self-
diagnosis, for discussion with their practitioner, or to find options for self-treatment with
over-the-counter remedies.
Health-related data covers a broad area and includes some of the following categories:
– disease awareness, self diagnosis and where to go for help
– pharmaceutical drugs that are prescription-only medicines approved for long term chronic conditions
– over-the-counter remedies, those treatments approved for short term symptomatic relief, requiring no prescription
– medical devices, either for drug delivery or monitoring state of health
– nutritional supplements
– and traditional homeopathic and alternative therapies which are unregistered.

A 2014 study by the team at Pew Research Center reported that 72% of North American
adult internet users looked online for health information in the last 12 months, beginning
with a search engine such as Google, Bing or Yahoo 3. This is supported by Google
themselves, who have identified that 1 in 20 searches are for health-related information –
this means a staggering 175 million searches per day.

Caregivers and health activities

Caregivers and health activities

Additionally, as technology continues to advance, there is an increasing trend in the
adoption of mobile and tablet devices to search for online health information. Manhattan
Research’s Cybercitizen Health ® U.S. 2012 study (the annual benchmarking study of how U.S. consumers use the internet, digital media, mobile devices and other technologies for health), found the number of U.S. adults using mobile phones for health information grew from 61 million in 2011 to 75 million in 2012, whilst the use of tablet technology almost doubled from 15 million to 29 million in the same time period 5. A trend which many expect to be mirrored throughout Europe and Asia-Pacific.

However, regardless of who is needing information and what format they are using, or
where they are in the world, access to quality and trusted online information is critical for
a better exchange of information, and improved patient safety.

Quality of health-related information found on today’s internet
The internet is a vast resource but should not always be taken at face value, by definition
the freedom of the internet could be its disadvantage when it comes to healthcare, where
quality of information is paramount for patient safety. Historically there is no central
control of quality and sadly the internet has been abused for unethical commercial
purposes. Many will be familiar with scams to provide fake pills, targeting vulnerable
consumers, at best providing useless products and at worst putting patients at risk.

In general the criteria for assessing the credibility of a website falls into three broad but
important categories:

  • Who is providing the information? Is it a government organisation, an educational institution, a non-profit organisation, or a company? Can they be trusted?
  • What is the source of the information? How neutral is it, are the claims supported with evidence or research?
  • Is the information accurate? And more importantly is the information up-to-date?

In reality, these criteria are not always considered by those seeking information, and
often ethical company websites are not always first choice when it comes to consumers
seeking health information, who still choose to go through the larger platforms of the
search engines. The consequence of this is that major producers of health-products are
not readily reaching those who need the information most.

Google today recognise this as a problem and is already changing its algorithms to
improve the quality of search results on both Google and via the Google search app. It
has made a commitment to take better control of health data and is partnering with the
FDA to provide its own range of basic medical facts on a wide number of diseases or
medical conditions. To maintain control this data is not taken from external sources,
instead they are using internal data, which is provided and validated by Google’s own
experts and its partners.

Implications of search engine changes for producers of health-care products

The changes from Google have several implications for the health-care products industry
– it seems, having a product listed on your website is simply not enough any more to
ensure engagement with consumers.

At one end of the spectrum major players and producers of prescription drugs may need
to partner with the big information players to have their information better delivered
through search engines. At the other end, smaller players, those providing over-the-
counter or unbranded remedies will likely have no official channel, and those providing
natural remedies, nutritional supplements etc., who traditionally have smaller marketing
budgets, will be left without a solution to deliver quality, trusted information to their
patients, customers and prospects.

The good news is that a new player in the game; myHealthbox could be the solution for
those companies still striving to engage with their customers.

myHealthbox home page

myHealthbox home page

The role of myHealthbox in healthcare’s new digital content revolution

Back in 2008, CEO and founder of myHealthbox Roberto Lattuada, identified the need for
an easy medicines search engine whilst having to administer antibiotics to his 2 year old
daughter during a family holiday abroad. Confronted with a package insert he was
unable to understand, he realised there was a gap in the market for a resource that would
provide trusted information on medicines in a language he understood, regardless of
where he was in the world. Since then Lattuada has strived to create myHealthbox as a
dedicated source of vital medical and health product information for consumers on all
platforms: PC, tablets and mobile devices.

In a few short years, myHealthbox has become a leading provider of digital healthcare
information services, providing freely available, trustworthy data for both consumers and
health professionals. myHealthbox gives pharma and healthcare companies a unique
platform for simple and interactive sharing of healthcare information regardless of
electronic device or geography.

Compared to inaccessible government websites or local databases which require a
subscription, myHealthbox is a free and easy to use service, and allows companies to
exchange high quality healthcare data in a simple digital format for web browsers,
smartphones and eReaders.

eLeaflet web site home page

eLeaflet web site home page

myHealthbox works on two levels. Firstly it is an intuitive search engine providing digital
patient information leaflets, ranging from traditional pharma medicines to over-the-
counter and alternative therapies, to medical devices, topical creams and nutritional
supplements. With already over 2 million leaflets available in 35 languages
myHealthbox is rapidly expanding. Every year the site receives over 5000 requests for
product information that is not listed, demonstrating the high demand for information
from consumers and professionals around the world, and particularly reflecting the
geographical trends in the rise of internet use, such as across Asia.

With its rapidly expanding database, pharma and healthcare companies are seeing the
advantages of myHealthbox for providing digital product information for consumers, and
technical documents or summary of product characteristics (SPCs) for professional users, so widening the availability and distribution of trusted high quality information which can be readily updated as required.

Secondly, myHealthbox uniquely offers additional valuable services to extend the
availability of healthcare data via the innovative eLeaflet format.

The eLeaflet is simple to read and navigate on different mobile platforms and has a
number of unique features:
• Extended product information with intelligent text in multiple languages, to legally
required formats
• Images with both audio and video for enhancing patient knowledge and confidence
• Interactive services such as electronic adverse reactions forms, contact forms or
customer satisfaction surveys to connect in real time
• Drug interaction alerts and package expiration alerts for improved patient safety

In a world of growing numbers of internet users and increasing demand for digital health-
related information, myHealthbox could be the solution for a single source of freely
available, up to date, quality healthcare information, benefitting consumers, professionals
and healthcare companies alike.

Where to get more information on myHealthbox
For consumers and member of the public simply register with myHealthbox for free
access to 1.5m patient leaflets. Click here to register https://www.myhealthbox.eu

For healthcare professionals, please register as a myHealthbox Professional User to
access more detailed medical information. Follow the link here to register
https://www.myhealthbox.eu

If you are a company and would like to know more about the myHealthbox eLeaflets as
the advanced technological solution to expanding your products exposure and improving
patient safety, register as a company here http://www.eleaflet.eu/ and refer to the
eLeaflet website for more information, then simply contact the sales team for advice on
products and pricing http://www.eleaflet.eu/pages/prices

myHealthbox, the myHealthbox logo, eLeaflet and the eLeaflet logos are all registered trademarks of Youbiquitus Mobile Solutions srl